Log In
BCIQ
Print this Print this
 

NI-1801

  Manage Alerts
Collapse Summary General Information
Company Novimmune S.A.
DescriptionKappa-lambda antibody, a human bispecific immunoglobulin G (IgG), targeting CD47 and mesothelin
Molecular Target CD47 ; Mesothelin
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationSolid tumors
Indication DetailsTreat mesothelin-expressing solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today